Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
quality_manual [2025/01/29 06:26] – admin | quality_manual [2025/02/06 06:24] (current) – admin | ||
---|---|---|---|
Line 13: | Line 13: | ||
- | =====Header===== | + | =====Header===== |
^Name^Unique ID^Edition^Date of Edition^ | ^Name^Unique ID^Edition^Date of Edition^ | ||
|Quality Manual|LSSTH/ | |Quality Manual|LSSTH/ | ||
Line 906: | Line 906: | ||
===7.3.1 General=== | ===7.3.1 General=== | ||
- | 1. The laboratory will select and use examination methods which have been validated for their intended use to assure the clinical accuracy of the examination for patient testing. | + | 1. The laboratory will select and use examination methods which have been validated for their intended use to assure the clinical accuracy of the examination for patient testing. |
- | + | ||
**NOTE:** Preferred methods are those specified in the instructions for use of in vitro diagnostic medical devices or those that have been published in established/ | **NOTE:** Preferred methods are those specified in the instructions for use of in vitro diagnostic medical devices or those that have been published in established/ | ||
Line 921: | Line 919: | ||
===7.3.2 Verification of examination methods=== | ===7.3.2 Verification of examination methods=== | ||
+ | [[DP for Verification of examination methods]] | ||
- The laboratory will have a procedure to verify that it can properly perform examination methods before introducing into use, by ensuring that the required performance, | - The laboratory will have a procedure to verify that it can properly perform examination methods before introducing into use, by ensuring that the required performance, | ||
- The performance specifications for the examination method confirmed during the verification process will be those relevant to the intended use of the examination results. | - The performance specifications for the examination method confirmed during the verification process will be those relevant to the intended use of the examination results. | ||
Line 976: | Line 974: | ||
Biological reference intervals and clinical decision limits will be defined, and their basis recorded, to reflect the patient population served by the laboratory, while considering the risk to patients. {{https:// | Biological reference intervals and clinical decision limits will be defined, and their basis recorded, to reflect the patient population served by the laboratory, while considering the risk to patients. {{https:// | ||
+ | [[Biological Reference Interval]] | ||
**NOTE:** Biological reference values, provided by the manufacturer can be used by the laboratory, if the population base of these values is verified and deemed acceptable by the laboratory | **NOTE:** Biological reference values, provided by the manufacturer can be used by the laboratory, if the population base of these values is verified and deemed acceptable by the laboratory | ||
Line 1013: | Line 1011: | ||
{{https:// | {{https:// | ||
{{https:// | {{https:// | ||
+ | [[Documentary Procedure for validation of examination of result]] | ||
a) The laboratory will have an IQC procedure for monitoring the ongoing validity of examination results, according to specified criteria, that verifies the attainment of the intended quality and ensures validity pertinent to clinical decision making. | a) The laboratory will have an IQC procedure for monitoring the ongoing validity of examination results, according to specified criteria, that verifies the attainment of the intended quality and ensures validity pertinent to clinical decision making. | ||
Line 1055: | Line 1053: | ||
==7.3.7.3 External quality assessment (EQA)== | ==7.3.7.3 External quality assessment (EQA)== | ||
- | |||
- | {{https:// | ||
{{https:// | {{https:// | ||
{{https:// | {{https:// | ||
+ | [[Procedure for Storage, Preparation, | ||
a) The laboratory will monitor its performance of examination methods, by comparison with results of other laboratories. This includes participation in EQA programmes appropriate to the examinations and interpretation of examination results, including POCT examination methods. | a) The laboratory will monitor its performance of examination methods, by comparison with results of other laboratories. This includes participation in EQA programmes appropriate to the examinations and interpretation of examination results, including POCT examination methods. | ||
Line 1141: | Line 1137: | ||
==7.4.1.2 Result review and release== | ==7.4.1.2 Result review and release== | ||
- | Results will be reviewed and authorized prior to release. The laboratory will ensure that authorized personnel review the results of examinations and evaluate them against IQC and, as appropriate, | + | Results will be reviewed and authorized prior to release. The laboratory will ensure that authorized personnel review the results of examinations and evaluate them against IQC and, as appropriate, |
==7.4.1.3 Critical result reports== | ==7.4.1.3 Critical result reports== | ||
- | {{https:// | + | [[7.4.1.3_critical_values|]]{{https:// |
When examination results fall within established critical decision limits: | When examination results fall within established critical decision limits: |